BAY-549 |
BAY-549 : Inhibitor of ROCK1, ROCK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ROCK1 |
|
|
| ROCK2 |
|
|
Inhibitor
0.5 to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - Trk-A 252 nM, Flt3 303 nM
Potency Assay Off-Target:
Kinase panel
Selectivity Assessment Description:
Selectivity >250 fold vs all other kinases (Upstate panel @ 10 µM)
Clean GPCR scan except for activi ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
LeadProfilingScreen closest off-targets @ 10 µM: SLC6A3 (DAT, human) IC50 = 0.4 µM
Potency Cellular
In Vitro
ROCK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1038/sj.bjp.0707484
ROCK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1038/sj.bjp.0707484
In Vivo Validations
Rat, Mouse, Dog
Dose: 1 mg/Kg, 3 mg/Kg, 10 mg/Kg, 0.1-0.3 mg/Kg IV
Route of delivery:
Intravenous, Oral
Plasma half life:
1.50 (m) 1.24 (r) 2.50 (d) h
Systemic clearance:
1.90 (m) 1.20 (r) 0.233 (d) L/h*Kg
DOI Reference: 10.1038/sj.bjp.0707484
Negative Control Compounds
BAY-4900
Chemical Information
| Molecular Formula | C18H13ClF2N6O |
| SMILEs | Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12 |
| InChI | InChI=1S/C18H13ClF2N6O/c1-8-7-24-17-15(8)12(2-3-23-17)28-16-10(20)4-9(5-11(16)21)25-14-6-13(19)26-18(22)27-14/h2-7H,1H3,(H,23,24)(H3,22,25,26,27) |
| Molecular weight | 402.08 Da |
| AlogP | 4.711020000000001 |
| HBond acceptors | 7 |
| HBond donors | 4 |
| Atoms | 41 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.